DRKS00028057Completed未知
ongitudinal serological study of SARS-CoV-2 positive individuals
KH Labor GmbH0 sites165 target enrollmentStarted: February 8, 2022Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 165
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Non-randomized controlled study
- Masking
- Open (masking not used)
Eligibility Criteria
- Ages
- one to one (—)
- Sex
- All
Inclusion Criteria
- •In addition to the signed declaration of consent, the prerequisite for participation is the clinical suspicion of an infection with SARS-CoV-2.
Exclusion Criteria
- •Exclusion criteria are: Primary immunodeficiency, severe liver or kidney disease, test persons taking immunomodulating medication, pregnant women and persons suffering from an oncological disease.
Investigators
Similar Trials
Not yet recruiting
Not Applicable
A population based survey on COVID-19 infection in Goa state among both urban and rural population.CTRI/2020/10/028384CROM Clinical Research Medical Tourism Pvt Ltd
Completed
Not Applicable
SARS-CoV-2 serology by mild symptoms of diseaseSARS-CoV-2 infection10047438NL-OMON50020Medlon b.v. Medische Diagnostiek39
Not yet recruiting
Not Applicable
Screening for SARS-CoV-2 infection and antibodies among staff members and clients attending homelessness services in Amsterdam, the Netherlands: a cross-sectional studyNL-OMON51056GGD Amsterdam250
Not yet recruiting
Not Applicable
Determination of the SARS-CoV-2/COVID-19 seroprevalence of patients in emergency rooms at the university hospitals in North Rhine-WestphaliaSeroprevalence of SARS-CoV-2 antibodies in emergency room patientsDRKS00029414Institut für Virologie Uniklinik Köln3,000
Active, not recruiting
Not Applicable
Prevalence of COVID19 antibodies among blood donors.CTRI/2021/01/030455ivetha M